Philips and Masimo have announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch.

The W1 will integrate with Philips’s enterprise patient monitoring ecosystem to advance telemonitoring and telehealth. The combined innovation draws upon the two global medical technology leaders’ extensive expertise in monitoring, connectivity, and automation.

Masimo W1 is the first watch to offer accurate, continuous pulse oximetry measurements and other insightful health data. Using Masimo’s secure health data cloud, patient information will be relayed to the Philips patient monitoring ecosystem for remote clinician surveillance. Hospital clinicians will be able to seamlessly and remotely monitor key health markers as their patients move throughout their homes and go about their daily lives. Physicians will be able to more confidently discharge patients knowing that their vital signs will still be monitored (via Masimo W1) and their physiological status tracked (via Philips dashboards), helping them catch possible patient deterioration sooner and make more informed interventions. This breakthrough combination of monitoring and connectivity technologies will enable numerous opportunities supporting early discharge initiatives, hospital-at-home programmes, and chronic illness management.

Bilal Muhsin, CEO at Masimo Healthcare, said: “Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere, and is an important part of our multi-year plan to bring the best of hospital monitoring to the home while continuing to improve access to quality hospital care.” Christoph Pedain, General Manager, Hospital Patient Monitoring at Philips, commented: “At Philips, we believe in an open ecosystem of information that enables physicians in their daily routine, allows for them to access and process vital patient information and deploy a wide range of measurements and patient-worn technologies. Our integration of the latest Masimo technologies is a testament to that strategy and we are delighted to deepen our relationship with Masimo.” The first of its kind, the Masimo W1 offers accurate, continuous health data and actionable health insights. Masimo W1 provides a variety of physiological data – including for the first time Hydration Index (Hi) alongside oxygen level (SpO2),* pulse rate, pulse rate variability, heart rate, respiration rate, pleth variability index, and perfusion index.

Masimo W1 for use in medical applications is CE marked and is pending FDA clearance.

For more information, visit: https://www.masimopersonalhealth.com/products/masimo-w1

Digital issue: Please click here for more information